Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,838 papers from all fields of science
Search
Sign In
Create Free Account
Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor
Known as:
Primary Borderline Peritoneal Epithelial Tumor
, Primary Peritoneal Serous Borderline Tumor
, Primary Peritoneal Borderline Epithelial Neoplasm
Expand
A serous epithelial tumor that arises from the peritoneum and histologically resembles the serous borderline tumors/atypical proliferative serous…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Abdominal Cavity
Epithelial Cells
Epithelium
Neoplastic Cell
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
A Clinicopathologic Study and Descriptive Analysis of “Atypical Endosalpingiosis”
Karen L. Talia
,
L. Fiorentino
,
J. Scurry
,
W. McCluggage
International Journal of Gynecological Pathology
2020
Corpus ID: 139106966
“Atypical endosalpingiosis” (AE) is a diagnostic term used variably among pathologists to denote peritoneal lesions exhibiting…
Expand
Review
2020
Review
2020
Primary Peritoneal Serous Borderline Tumors as a Therapeutic Challenge: a Systematic Review of the Literature
J. Pape
,
E. Samartzis
,
M. Choschzick
,
D. Fink
,
P. Imesch
SN Comprehensive Clinical Medicine
2020
Corpus ID: 211217368
Primary peritoneal serous borderline tumors (PPSBT) are rare neoplasms that can present as an incidental finding at laparoscopy…
Expand
2015
2015
A phase III randomized controlled clinical trial of carboplatin and paclitaxel alone or in combination with bevacizumab followed by bevacizumab and secondary cytoreductive surgery in platinum…
R. Coleman
,
M. Brady
,
+7 authors
D. O’Malley
2015
Corpus ID: 72960751
2015
2015
EFFECT OF ALOE VERA IN LOWERING BLOOD GLUCOSE LEVELS ON DIABETES MELITUS
Rr. Agatha Rhana Aveonita
2015
Corpus ID: 70528252
Abstract Diabetes mellitus (DM) is an illness or a chronic metabolic disorder with multiple etiology that is characterized by…
Expand
2012
2012
CT appearance of primary peritoneal serous borderline tumour: a rare epithelial tumour of the peritoneum.
H. Go
,
H. Hong
,
J. W. Kim
,
J. Y. Woo
British Journal of Radiology
2012
Corpus ID: 207212154
Primary peritoneal serous borderline tumour (PPSBT) is a rare epithelial neoplasm which is histologically identical to serous…
Expand
Review
2009
Review
2009
Versicherungsmedizinische Aspekte bei peritonealen Mesotheliomen und sonstigen peritonealen Tumoren
V. Neumann
,
S. Löseke
,
A. Tannapfel
Medizinische Klinik
2009
Corpus ID: 1268552
ZusammenfassungMaligne peritoneale Mesotheliome treten zumeist bei männlichen Patienten auf, wobei das Erkrankungsalter im Median…
Expand
2009
2009
An incidental peritoneal serous borderline tumor during laparoscopy for endometriosis.
A. Tinelli
,
A. Malvasi
,
M. Pellegrino
European Journal of Gynaecological Oncology
2009
Corpus ID: 33194989
BACKGROUND Primary peritoneal serous borderline tumor (PPSBT) is an uncommon lesion, histologically indistinguishable from non…
Expand
Review
2007
Review
2007
Primary peritoneal serous borderline tumors.
Robert L Hutton
,
S. Dalton
Archives of Pathology & Laboratory Medicine
2007
Corpus ID: 35186057
CONTEXT Primary peritoneal serous borderline tumor is a rare epithelial proliferation that can present as an incidental finding…
Expand
2007
2007
Primary peritoneal serous borderline tumor presenting as an "adnexal torsion" gynecologic emergency.
P. Lin
,
S. Ueng
,
M. Tseng
Taiwanese Journal of Obstetrics & Gynecology
2007
Corpus ID: 7399705
Highly Cited
2005
Highly Cited
2005
Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
N. Ordóñez
Human Pathology
2005
Corpus ID: 23594586
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE